# FDA Inspection 1174430 - David Butuk - June 30, 2022

Source: https://www.keypedia.com/records/fda_inspections/david-butuk/5a76d8b9-b27f-45d0-9147-43b2f7efce6d
Source feed: FDA_Inspections

> FDA Inspection 1174430 for David Butuk on June 30, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1174430
- Company Name: David Butuk
- Inspection Date: 2022-06-30
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1174430 - 2022-06-30](https://www.keypedia.com/records/fda_inspections/david-butuk/7f284a7c-fe19-40b2-9528-a5598a54fbdb)
- [FDA Inspection 1018515 - 2017-06-23](https://www.keypedia.com/records/fda_inspections/david-butuk/66ce7802-6124-4c83-8072-3f5768f15b4e)

Company: https://www.keypedia.com/companies/david-butuk/471e477b-d382-4db1-b1eb-02e927a96650

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d